Inhibitory Effect of TrxR Inhibitor Ag (Ⅰ) Schiff Base Complex Against Cervical Cancer Via ROS-mediated ASK1/MAPK
Jian-Jun Liu1, Jia-Hua Zou1, Bin Dong2
1Guangdong Provincial Key Laboratory of Bioengineering Medicine, National Engineering Research Center of Genetic Medicine, Institute of Biomedicine, College of Life Science and Technology, Jinan University, Guangzhou, 510632, China.
Abstract:
Schiff base complexes possess many biological activities, including antibacterial and antitumor activities. However, the anti-cervical cancer activity of Ag (Ⅰ) Schiff base complex or its corresponding molecular mechanism remains limited. Here, we showed that Ag (Ⅰ) Schiff base complex Ag34 significantly inhibited the proliferation of cervical cancer cells. Subsequent studies on the anti-cervical cancer mechanism of Ag34 revealed that Ag34 inactivated TrxR, which led to ROS accumulation. Ag34-induced ROS accumulation promoted ASK1/MAPK signaling activation and autophagy, thereby triggering apoptosis of cervical cancer cells. Taken together, Ag34 has the potential to be used in the treatment of cervical cancer.
More Related Videos
06:00Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
08:49Identification of Mediators of T-cell Receptor Signaling via the Screening of Chemical Inhibitor Libraries
Published on: January 22, 2019
Related Concept Videos
Inhibition of Cdk Activity
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
The Intrinsic Apoptotic Pathway
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
